1.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: IRB#10BN132, NCT01502280
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCC 08309, NCI-2009-01442, NCT01024907
|
|
3.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: OHSU-922, ONC-02059-L, 922, 7328, OHSU-7328, OHSU-ONC-02059-L, CASE-CCF-6385, NCT00075387
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000448883, UCSF-99102, BTRC-9902, UCSF-H7858-16278-07, NCT00313729
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: 05-122, MSKCC-05122, NCT00445965
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-08-C-0015, 08-C-0015, NCI-H6Q-MC-S033, NCT00559923
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000632931, UCSF-H7858-32860-01, 08109, CRAD001CUS58T, H7858-32860-01, NCT00831324
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 104974, NCT00961090
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000066489, BC-BT-9, NCT00003457
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000066512, BC-BT-21, NCT00003475
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CERN09-02, NCT01295944
|
|
12.
|
Phase: Phase I Type: Treatment Status: Active Age: 3 to 70 Sponsor: Other Protocol IDs: MCW-7594, MCW-CHW-511, MCW-CHW-9411, NCI-V95-0652, NCT00002647
|
|
13.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: IRUSZACT0073 (06-0870), NCT00721292
|
|
14.
|
Phase: Phase I Type: Diagnostic, Treatment Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: OHSU-3678, 26XS293, 3678, SOL-07083-LX, NCT00769093
|
|
15.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: DTI-021, 5R43CA132257-02, NCT01048008
|
|
16.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: 07082, NCI-2010-00303, NCT01082926
|
|
17.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: UCLA 07-09-008, R01CA125244, NCT01144247
|
|
18.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 3 to 21 Sponsor: NCI Protocol IDs: 110047, 11-C-0047, NCT01259479
|
|
19.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-01139, 11D.101, NCT01378481
|
|
20.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 120005, 12-C-0005, NCT01468324
|
|
21.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: I 191511, NCI-2011-03568, NCT01522820
|
|
22.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: MC1078, NCI-2010-01607, 10-001904, NCT01165632
|
|
23.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCC 08310, NCT01212731
|
|
24.
|
Phase: No phase specified Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: 2011OC057, MT2011-09C, NCT01505569
|
|
25.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: LAASR01, NCT01651078
|